America Clinical Chemistry Analyzer market projected to reach $19,231.0 million by 2019

According to new market research, the global clinical chemistry analyzers market, by product, was valued at $13,584.0 million in 2014 and is projected to reach $19,231.0 million by 2019, at a CAGR of 7.2% from 2014 to 2019. The leading segment, point of care under IVD, is also expected to reach $8,919.0 million by 2019 at a CAGR of 7.4%.


PDF brochure of the research


Clinical chemistry analyzers are the devices/instruments that read and analyse the solutions in the human body. The fluids present in the body are considered to be one of the most important parts inside the body. The main function of the fluids is to connect plethora of cells to transport essential minerals such as vitamins and calcium through arteries and veins. The content of minerals in body fluids must be accurate in order to avoid diseases such as hyponatremia.


The Americas segment is the largest market for clinical chemistry analyzers globally, having accounted a share of 40.6% in 2013.  However, the market is experiencing saturation in this region; the major influencing factor for its large market share and growth is the healthcare expenditure.


Discuss more on this study with research analyst at –


The U.S. was the largest segment in the Americas clinical chemistry analyzers market in 2013, having registered market value of $939.8 million in 2013. Aging population is one of the primary growth drivers in this region. According to the International Journal of Epidemiology, the proportion of population aged over 65 years is expected to increase from 12.7% in 2000 to 20.3% by 2050, while the proportion of population above the age of 85 is expected to increase from 1.6% in 2000 to 4.8% in 2050. The focus is, hence, more on preventative care of diseases associated with geriatrics, which include cancer, stroke, diabetes, and cardiovascular diseases (CVD). This has led to an increased demand for rapid diagnostic tests, which in turn is fostering the growth of the clinical chemistry analyzers market in the Americas. Furthermore, the major manufacturers of clinical chemistry analyzers are based in the U.S., thereby giving them easy access to this market. The presence of these major companies is also among the major factors resulting in the large share of the Americas market, globally.


The key companies of this market are F. Hoffmann La-Roche (Switzerland) Siemens AG (Germany), Abbott Laboratories (U.S.), Danaher Corporation (US), Ortho Clinical Diagnostics (US), and Thermo Fisher ScientificInc., (U.S.)


The statistics are given by “America Clinical Chemistry Analyzer Market – Global Forecast 2019”. The study aim to provide pictorial methodology, detailed sizing of all dependent markets, industry trends, market share, market growth analysis and projection supported by market estimates and forecasts.


Browse table of contents and report description at


Inquiries or queries related to this research, ask at ‘Inquiries before buying’


About Report Publisher:


MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.



Mr. Priyank Tiwari

UNIT no 802, Tower No. 7, SEZ

Magarpatta City, Hadapsar

Pune, Maharashtra 411013, India

Tel – +1-888-502-0539